MOVES- Rothschild, Northern Trust, Bluemountain Capital
May 24 The following financial services industry appointments were announced on Wednesday. To inform us of other job changes, email firstname.lastname@example.org.
March 6 TG Therapeutics Inc said a late-stage study testing a combination of its experimental cancer drug ublituximab and AbbVie Inc's Imbruvica was superior to Imbruvica alone in high-risk patients with a common form of leukemia.
The trial involved adult patients with high-risk chronic lymphocytic leukemia, who had undergone at least one prior therapy. (Reporting by Natalie Grover in Bengaluru; Editing by Martina D'Couto)
* Shares down 3 percent (Recasts, adds comment from BMO Canada head)